Page 191 - ASHG 2012 Annual Meeting Program Guide

180
POSTER SESSIONS
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
1714
T Assessing change in quality of life in patients
participating in Additional KIF6 Risk Offers Better
Adherence to Statins trial.
H. R. Superko, S. L. Charland,
B. C. Agatep, V. Herrera, M. Ryvkin, B. J. Schrader, J.
Shabbeer, J. J. Devlin, E. J. Stanek.
1715
T Heritability of John Henryism, and correlation
between John Henryism and hypertension in the
Jackson Heart Study.
S. G. Buxbaum, P. Goel, W. White,
M. Gregoski, S. H. Dunn.
Genetic Counseling and Clinical
Testing
1716
W Assessment of health information technology
tools use among cancer genetic counselors.
M. Doerr,
T. Vu, C. Eng.
1717
W Behavior and food-related concerns in
children with Smith-Magenis syndrome are similar
to Prader-Willi syndrome.
L. V. Barton, T. P. York, S. H.
Elsea.
1718
W Genetic counseling future in historicist Middle
East culture.
A. Haghighatfard, M. Mahdavi.
1719
W Pre-conception genetic counseling awareness
in a post-secondary educational institute.
A. Neogi, A.
Mahesh, D. Jalaluddin Shariff.
1720
W Genetic counseling in India: Challenges in a
developing country.
R. Puri, U. Kotecha, R. Saxena, J.
Verma, S. Movva, S. Kohli, I. C. Verma.
1721
W A novel
GLI2
mutation and discordant
holoprosencephaly phenotypes in monozygotic twins.
C. Quindipan, M. Van Hirtum-Das, S. Saitta.
1722
W Furnishing appropriate information on
mitochondrial diseases to patients and their families.
Y. Sato, Y. Goto.
1723
W A special thalassemia case with probable
uniparental disomy.
Y. Zhang, J. Wu, M. Q. Mai, A. H. Yin,
H. K. Ding, D. Q. Qin, Q. Y. Du, J. Q. Liang.
1724
W Understanding the needs of parents of children
with a genetic diagnosis: Can it improve clinical
practice?
L. Bryson, J. Dunlop, A. Anderson, J. Berg.
1725
W A diagnostic assay for predicting medullary
cystic kidney disease type 1.
B. Blumenstiel, M.
DeFelice, A. Kirby, A. Gnirke, A. Bleyer, S. Gabriel, M. Daly.
1726
W Studding the importance of common
a
-
deletions among
b
-
thalassemia minor individuals in
an Iranian population based on their frequencies and
CBC indexes.
A. Moosavi, M. Karimipoor, S. Zeinali, B.
Zarbakhsh.
1727
W Genomic data interpretation challenges:
Healthy older relatives as super controls.
M. S.
Naslavsky, R. C. M. Pavanello, N. C. V. Lourenço, A.
Danda, R. Shah, S. Prasanna, P. Chandna, R. Chopra,
S. Danda.
1702
T Cardiomyopathy as an emerging phenotype
in hereditary inclusion body myopathy.
S. Siebel, S.
McGehee, A. Brofferio, C. Ciccone, M. Huizing, L. Medne,
R. Finkel, J. McKew, W. A. Gahl, N. Carrillo-Carrasco.
1703
T Role of the Pro12Ala, G972R, G1057D
polymorphism of the
PPAR-
g
2,
IRS1
and
IRS2
genes
in type 2 diabetes and coronary artery disease.
S. Vats,
K. Matharoo, V. Sambyal, A. J. S. Bhanwer.
1704
T Genetic causes of cardiomyopathy in pediatric
transplant recipients.
L. Zahavich, A. Al-Maawali, A.
Dipchand, C. Manlhiot, S. Bowdin.
1705
T Is your mother or father’s family history more
important when assessing your risk of having high
blood pressure: Studies in humans and mice.
C. L.
Chiu, C. T. Morgan, S. J. Lupton, S. Lujic, J. M. Lind.
1706
T Analysis of variations from exome sequence
data with subclinical cardiovascular disease in the
diabetes heart study: Variations from exome sequence
data with subclinical cardiovascular disease in the
diabetes heart study.
J. Adams, A. Cox, B. Freedman, J.
Carr, D. Bowden.
1707
T Common familial effects on ischemic stroke and
myocardial infarction: A Swedish national cohort study.
K. Kasiman, C. Lundholm, S. Sandin, N. Malki, P. Sparén,
E. Ingelsson.
1708
T Jervell and Lange-Nielson syndrome:
Homozygous missense mutation in
KCNQ1
in a Turkish
family.
S. Temel, O. Bostan, H. Cangul, E. Cil.
1709
T Genetic risk profiles for incident coronary
heart disease using a 28 SNP marker panel in four
prospective cohorts.
E. Tikkanen, A. S. Havulinna, A.
Palotie, V. Salomaa, S. Ripatti.
1710
T Vascular stiffness in a healthy high risk African
American population is modified by the extent of
European admixture.
D. Vaidya, R. A. Mathias, L. R.
Yanek, L. C. Becker, D. M. Becker.
1711
T A Dutch founder mutation in the cardiac
regulatory light chain (MYL2).
I. P. C. Krapels, G. R. F.
Claes, M. B. Hoos, Y. E. G. Barrois, J.-W. Sels, A. T. J.
M. Helderman-van den Enden, P. G. A. Volders, H. J. M.
Smeets, A. Van den Wijngaard.
1712
T Genome-wide DNA methylation profiling in
myocardial infarction.
A. Russo, G. Fiorito, S. Guarrera,
C. Di Gaetano, F. Ricceri, F. Rosa, A. Allione, F. Voglino,
L. Iacoviello, M. C. Giurdanella, R. Tumino, S. Grioni, V.
Krogh, A. Mattiello, S. Panico, P. Vineis, C. Sacerdote, G.
Matullo.
1713
T Common cardiovascular disease risk factors are
associated with mitochondrial DNA levels.
S. Mitchell,
K. Brown-Gentry, M. Allen, L. Hunt, P. Mayo, N. Schnetz-
Boutaud, D. C. Crawford, D. G. Murdock.